OptiMalVax: Optimizing a deployable high efficacy malaria vaccine
PROGRAM FOR APPROPRIATE TECHNOLOGYIN HEALTH
participó en un
H2020:
H2020-SC1-2016-2017
A highly effective malaria vaccine against Plasmodium falciparum should help prevent half a million deaths from malaria each year. New vacc...
2016-12-09 - 2022-12-31 | Financiado
2016-12-09 - 2022-12-31 | Financiado
INYVAX: Optimisation of the development of Poverty Related Diseases PRD vaccines by a transversal approach...
PROGRAM FOR APPROPRIATE TECHNOLOGYIN HEALTH
participó en un
FP7:
A number of new vaccines are being developed against Poverty-Related infectious diseases of major public health importance at a global level...
Financiado
Financiado
* No se disponen de datos de la empresa actual.